Sign In
test

Anders Hove

Acorn Capital Advisors, Llc

Assets Managed
$351.838M
Holdings
22
Last Quarter
2026 - Q1
Filed Date
6d ago
Growth Rate
19.22%(2Q avg: 34.52%)
Sustained Growth
4 quarters

Portfolio positions

This chart displays the top 10 holdings in Acorn Capital Advisors, Llc's 2026 - Q1 portfolio, based on their 13F SEC filing, out of a total of 22 positions.

Assets under management

The assets under management (AUM) of Acorn Capital Advisors, Llc over the past 10 years (40 quarters) show continuous growth in total asset value over the last 4 quarters. As of the latest 13F SEC filing for 2026 - Q1, they manage 351.838M in assets, with a quarterly growth rate of 19.22% and a 2-quarter average growth rate of 34.52%. The portfolio is managed by Anders Hove, and others.

Portfolio holdings

InvestmentPortfolio %Reported Value
TERN
Terns Pharmaceuticals Inc
Recent Activity
26.17%
$92.063M
1.746M shares@ $52.72 avg price
CGON
Cg Oncology Inc
Recent Activity
Decreased -0.08%
21.77%
$76.58M
1.131M shares@ $67.74 avg price
URGN
Urogen Pharma Ltd
Recent Activity
Increased 15.54%
8.56%
$30.088M
1.673M shares@ $17.99 avg price
PBYI
Puma Biotechnology Inc
Recent Activity
7.51%
$26.399M
4.131M shares@ $6.4 avg price
TRVI
Trevi Therapeutics Inc
Recent Activity
7.28%
$25.588M
2.145M shares@ $11.94 avg price
CADL
Candel Therapeutics Inc
Recent Activity
Increased 35.56%
4.9%
$17.21M
3.498M shares@ $4.92 avg price
BCAX
Bicara Therapeutics Inc
Recent Activity
3.64%
$12.797M
643,382 shares@ $19.89 avg price
OKUR
Onkure Therapeutics Inc-a
Recent Activity
3.35%
$11.756M
2.84M shares@ $4.14 avg price
JBIO
Jade Biosciences Inc
Recent Activity
New Position
3.15%
$11.054M
786,760 shares@ $14.05 avg price
TARA
Protara Therapeutic Inc
Recent Activity
2.6%
$9.129M
1.752M shares@ $5.21 avg price

1-10 of 22